Browsing Tag
Tanner Health
2 posts
Artrya (ASX: AYA) shares rise 3.3% as A$74m cash backs US Salix commercial rollout
Artrya has moved from clinical development into early United States commercialisation, with three health-system customers and its first Salix revenues now established. The company enters FY27 with A$74 million of cash and no debt, but FY26 statutory revenue remained only A$28,000 while operating investment drove the annual loss materially higher.
Can Tanner Health’s InStockRx deal turn wasted hospital drugs into a hidden efficiency win?
Find out how Tanner Health and InStockRx are tackling hospital medication waste, pharmacy efficiency and patient access through smarter stewardship.